Thomas I. H. Dubin, SVP & Chief Legal Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 172,393 shares at $104.94 ($18.6M) on 2012-07-31, disclosed to the SEC on 2012-07-31.
Seasonal sale ($18.6M) by SVP & Chief Legal Officer — this insider has traded ALXN in July in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.76 | 6,268 | $663K | 3.6% |
| 2 | $106.14 | 668 | $71K | 0.4% |
| 3 | $106.35 | 16,642 | $1.8M | 9.5% |
| 4 | $107.57 | 51,303 | $5.5M | 29.6% |
| 5 | $108.56 | 68,632 | $7.5M | 40.0% |
| 6 | $109.28 | 28,200 |
| $3.1M |
| 16.5% |
| 7 | $104.94 | 680 | $71K | 0.4% |
| Total | $108.04 avg | 172,393 | $18.6M | 100% |
| Filing → |
| ALXN | SELL | 2012-05-31 | $9.5M | — | Filing → |
| ALXN | SELL | 2012-03-16 | $5.9M | — | Filing → |
| ALXN | SELL | 2012-02-23 | $7.5M | — | Filing → |